San Francisco Bay Area biotech stories.
Monday, August 27, 2012
Daniel O'Day to lead Roche Pharma as Pascal Soriot moves to AstraZeneca
, the former president and CEO of Roche Molecular Diagnostics in Pleasanton, will become chief operating officer of Roche Pharma as
, who oversaw the tricky integration of
Inc. into Roche, takes the helm of rival drug maker AstraZeneca
. O’Day’s appointment is an important one, underscoring the Swiss drug maker’s commitment to developing companion diagnostics for its drugs. As COO of Roche Diagnostics since 2010, he has been a member of Roche’s executive committee. Roche CEO
in a press release
late Monday night that O’Day has “a very impressive track record” in diagnostics and pharmaceuticals.
Share to Twitter
Share to Facebook
Share to Pinterest
Roche Molecular Diagnostics
Post a Comment
Post Comments (Atom)